+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Antimicrobial Therapeutics Market 2024-2028

  • PDF Icon

    Report

  • 175 Pages
  • June 2024
  • Region: Global
  • TechNavio
  • ID: 5025029
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The antimicrobial therapeutics market is forecasted to grow by USD 56.1 billion during 2023-2028, accelerating at a CAGR of 5.82% during the forecast period. The report on the antimicrobial therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by recent drug approvals and robust pipeline, initiatives from government agencies in pharmaceutical industry, and rising awareness about microbial diseases.

The antimicrobial therapeutics market is segmented as below:

By Application

  • Antiviral
  • Antibacterial
  • Antifungal
  • Antiparasitic

By End-user

  • Pharmacies
  • Hospitals and clinics
  • Research and academic institutes

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increase in research and development of therapeutic vaccines as one of the prime reasons driving the antimicrobial therapeutics market growth during the next few years. Also, increased disease diagnostic modalities and increasing research on combination therapies will lead to sizable demand in the market.

The report on the antimicrobial therapeutics market covers the following areas:

  • Antimicrobial therapeutics market sizing
  • Antimicrobial therapeutics market forecast
  • Antimicrobial therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antimicrobial therapeutics market vendors that include AbbVie Inc., Astellas Pharma Inc., Bavarian Nordic AS, Biocidium Biopharmaceuticals Inc., Bristol Myers Squibb Co., Cadila Pharmaceuticals Ltd., CSL Ltd., Emergent BioSolutions Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Johnson and Johnson Services Inc., Merck and Co. Inc., Mitsubishi Corp., Novartis AG, Novavax Inc., Pfizer Inc., Sanofi SA, and Wockhardt Ltd. Also, the antimicrobial therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ billion)
Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Antimicrobial Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Antimicrobial Therapeutics Market 2018 - 2022 ($ billion)
4.2 Application segment analysis 2018 - 2022
Historic Market Size - Application Segment 2018 - 2022 ($ billion)
4.3 End-user segment analysis 2018 - 2022
Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
6.1 Market segments
Chart on Application - Market share 2023-2028 (%)
Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
6.3 Antiviral - Market size and forecast 2023-2028
Chart on Antiviral - Market size and forecast 2023-2028 ($ billion)
Data Table on Antiviral - Market size and forecast 2023-2028 ($ billion)
Chart on Antiviral - Year-over-year growth 2023-2028 (%)
Data Table on Antiviral - Year-over-year growth 2023-2028 (%)
6.4 Antibacterial - Market size and forecast 2023-2028
Chart on Antibacterial - Market size and forecast 2023-2028 ($ billion)
Data Table on Antibacterial - Market size and forecast 2023-2028 ($ billion)
Chart on Antibacterial - Year-over-year growth 2023-2028 (%)
Data Table on Antibacterial - Year-over-year growth 2023-2028 (%)
6.5 Antifungal - Market size and forecast 2023-2028
Chart on Antifungal - Market size and forecast 2023-2028 ($ billion)
Data Table on Antifungal - Market size and forecast 2023-2028 ($ billion)
Chart on Antifungal - Year-over-year growth 2023-2028 (%)
Data Table on Antifungal - Year-over-year growth 2023-2028 (%)
6.6 Antiparasitic - Market size and forecast 2023-2028
Chart on Antiparasitic - Market size and forecast 2023-2028 ($ billion)
Data Table on Antiparasitic - Market size and forecast 2023-2028 ($ billion)
Chart on Antiparasitic - Year-over-year growth 2023-2028 (%)
Data Table on Antiparasitic - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Application
Market opportunity by Application ($ billion)
Data Table on Market opportunity by Application ($ billion)
7 Market Segmentation by End-user
7.1 Market segments
Chart on End-user - Market share 2023-2028 (%)
Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
7.3 Pharmacies - Market size and forecast 2023-2028
Chart on Pharmacies - Market size and forecast 2023-2028 ($ billion)
Data Table on Pharmacies - Market size and forecast 2023-2028 ($ billion)
Chart on Pharmacies - Year-over-year growth 2023-2028 (%)
Data Table on Pharmacies - Year-over-year growth 2023-2028 (%)
7.4 Hospitals and clinics - Market size and forecast 2023-2028
Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
7.5 Research and academic institutes - Market size and forecast 2023-2028
Chart on Research and academic institutes - Market size and forecast 2023-2028 ($ billion)
Data Table on Research and academic institutes - Market size and forecast 2023-2028 ($ billion)
Chart on Research and academic institutes - Year-over-year growth 2023-2028 (%)
Data Table on Research and academic institutes - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by End-user
Market opportunity by End-user ($ billion)
Data Table on Market opportunity by End-user ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ billion)
Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ billion)
Data Table on US - Market size and forecast 2023-2028 ($ billion)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ billion)
Data Table on China - Market size and forecast 2023-2028 ($ billion)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ billion)
Data Table on France - Market size and forecast 2023-2028 ($ billion)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ billion)
Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.4 Astellas Pharma Inc.
Astellas Pharma Inc. - Overview
Astellas Pharma Inc. - Product / Service
Astellas Pharma Inc. - Key news
Astellas Pharma Inc. - Key offerings
12.5 Bavarian Nordic AS
Bavarian Nordic AS - Overview
Bavarian Nordic AS - Product / Service
Bavarian Nordic AS - Key offerings
12.6 Biocidium Biopharmaceuticals Inc.
Biocidium Biopharmaceuticals Inc. - Overview
Biocidium Biopharmaceuticals Inc. - Product / Service
Biocidium Biopharmaceuticals Inc. - Key offerings
12.7 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.8 Cadila Pharmaceuticals Ltd.
Cadila Pharmaceuticals Ltd. - Overview
Cadila Pharmaceuticals Ltd. - Product / Service
Cadila Pharmaceuticals Ltd. - Key offerings
12.9 CSL Ltd.
CSL Ltd. - Overview
CSL Ltd. - Business segments
CSL Ltd. - Key news
CSL Ltd. - Key offerings
CSL Ltd. - Segment focus
12.10 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.11 Gilead Sciences Inc.
Gilead Sciences Inc. - Overview
Gilead Sciences Inc. - Product / Service
Gilead Sciences Inc. - Key offerings
12.12 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.13 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.14 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
12.15 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.16 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.17 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Antimicrobial Therapeutics Market 2018 - 2022 ($ billion)
Exhibits 21: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits 22: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on Application - Market share 2023-2028 (%)
Exhibits 33: Data Table on Application - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by Application
Exhibits 35: Data Table on Comparison by Application
Exhibits 36: Chart on Antiviral - Market size and forecast 2023-2028 ($ billion)
Exhibits 37: Data Table on Antiviral - Market size and forecast 2023-2028 ($ billion)
Exhibits 38: Chart on Antiviral - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Antiviral - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on Antibacterial - Market size and forecast 2023-2028 ($ billion)
Exhibits 41: Data Table on Antibacterial - Market size and forecast 2023-2028 ($ billion)
Exhibits 42: Chart on Antibacterial - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Antibacterial - Year-over-year growth 2023-2028 (%)
Exhibits 44: Chart on Antifungal - Market size and forecast 2023-2028 ($ billion)
Exhibits 45: Data Table on Antifungal - Market size and forecast 2023-2028 ($ billion)
Exhibits 46: Chart on Antifungal - Year-over-year growth 2023-2028 (%)
Exhibits 47: Data Table on Antifungal - Year-over-year growth 2023-2028 (%)
Exhibits 48: Chart on Antiparasitic - Market size and forecast 2023-2028 ($ billion)
Exhibits 49: Data Table on Antiparasitic - Market size and forecast 2023-2028 ($ billion)
Exhibits 50: Chart on Antiparasitic - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Antiparasitic - Year-over-year growth 2023-2028 (%)
Exhibits 52: Market opportunity by Application ($ billion)
Exhibits 53: Data Table on Market opportunity by Application ($ billion)
Exhibits 54: Chart on End-user - Market share 2023-2028 (%)
Exhibits 55: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 56: Chart on Comparison by End-user
Exhibits 57: Data Table on Comparison by End-user
Exhibits 58: Chart on Pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits 59: Data Table on Pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits 60: Chart on Pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on Pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 62: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
Exhibits 63: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
Exhibits 64: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibits 65: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibits 66: Chart on Research and academic institutes - Market size and forecast 2023-2028 ($ billion)
Exhibits 67: Data Table on Research and academic institutes - Market size and forecast 2023-2028 ($ billion)
Exhibits 68: Chart on Research and academic institutes - Year-over-year growth 2023-2028 (%)
Exhibits 69: Data Table on Research and academic institutes - Year-over-year growth 2023-2028 (%)
Exhibits 70: Market opportunity by End-user ($ billion)
Exhibits 71: Data Table on Market opportunity by End-user ($ billion)
Exhibits 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 73: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 74: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 75: Chart on Geographic comparison
Exhibits 76: Data Table on Geographic comparison
Exhibits 77: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 78: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 79: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 82: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 83: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 86: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 87: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 94: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 95: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 98: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 99: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 102: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 103: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibits 106: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibits 107: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 109: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 110: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 111: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 112: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 113: Market opportunity By Geographical Landscape ($ billion)
Exhibits 114: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 115: Impact of drivers and challenges in 2023 and 2028
Exhibits 116: Overview on criticality of inputs and factors of differentiation
Exhibits 117: Overview on factors of disruption
Exhibits 118: Impact of key risks on business
Exhibits 119: Companies covered
Exhibits 120: Matrix on companies position and classification
Exhibits 121: AbbVie Inc. - Overview
Exhibits 122: AbbVie Inc. - Product / Service
Exhibits 123: AbbVie Inc. - Key news
Exhibits 124: AbbVie Inc. - Key offerings
Exhibits 125: Astellas Pharma Inc. - Overview
Exhibits 126: Astellas Pharma Inc. - Product / Service
Exhibits 127: Astellas Pharma Inc. - Key news
Exhibits 128: Astellas Pharma Inc. - Key offerings
Exhibits 129: Bavarian Nordic AS - Overview
Exhibits 130: Bavarian Nordic AS - Product / Service
Exhibits 131: Bavarian Nordic AS - Key offerings
Exhibits 132: Biocidium Biopharmaceuticals Inc. - Overview
Exhibits 133: Biocidium Biopharmaceuticals Inc. - Product / Service
Exhibits 134: Biocidium Biopharmaceuticals Inc. - Key offerings
Exhibits 135: Bristol Myers Squibb Co. - Overview
Exhibits 136: Bristol Myers Squibb Co. - Product / Service
Exhibits 137: Bristol Myers Squibb Co. - Key news
Exhibits 138: Bristol Myers Squibb Co. - Key offerings
Exhibits 139: Cadila Pharmaceuticals Ltd. - Overview
Exhibits 140: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits 141: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits 142: CSL Ltd. - Overview
Exhibits 143: CSL Ltd. - Business segments
Exhibits 144: CSL Ltd. - Key news
Exhibits 145: CSL Ltd. - Key offerings
Exhibits 146: CSL Ltd. - Segment focus
Exhibits 147: F. Hoffmann La Roche Ltd. - Overview
Exhibits 148: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 149: F. Hoffmann La Roche Ltd. - Key news
Exhibits 150: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 151: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 152: Gilead Sciences Inc. - Overview
Exhibits 153: Gilead Sciences Inc. - Product / Service
Exhibits 154: Gilead Sciences Inc. - Key offerings
Exhibits 155: GlaxoSmithKline Plc - Overview
Exhibits 156: GlaxoSmithKline Plc - Business segments
Exhibits 157: GlaxoSmithKline Plc - Key news
Exhibits 158: GlaxoSmithKline Plc - Key offerings
Exhibits 159: GlaxoSmithKline Plc - Segment focus
Exhibits 160: Johnson and Johnson Services Inc. - Overview
Exhibits 161: Johnson and Johnson Services Inc. - Business segments
Exhibits 162: Johnson and Johnson Services Inc. - Key news
Exhibits 163: Johnson and Johnson Services Inc. - Key offerings
Exhibits 164: Johnson and Johnson Services Inc. - Segment focus
Exhibits 165: Merck and Co. Inc. - Overview
Exhibits 166: Merck and Co. Inc. - Business segments
Exhibits 167: Merck and Co. Inc. - Key news
Exhibits 168: Merck and Co. Inc. - Key offerings
Exhibits 169: Merck and Co. Inc. - Segment focus
Exhibits 170: Novartis AG - Overview
Exhibits 171: Novartis AG - Business segments
Exhibits 172: Novartis AG - Key news
Exhibits 173: Novartis AG - Key offerings
Exhibits 174: Novartis AG - Segment focus
Exhibits 175: Pfizer Inc. - Overview
Exhibits 176: Pfizer Inc. - Product / Service
Exhibits 177: Pfizer Inc. - Key news
Exhibits 178: Pfizer Inc. - Key offerings
Exhibits 179: Sanofi SA - Overview
Exhibits 180: Sanofi SA - Business segments
Exhibits 181: Sanofi SA - Key news
Exhibits 182: Sanofi SA - Key offerings
Exhibits 183: Sanofi SA - Segment focus
Exhibits 184: Inclusions checklist
Exhibits 185: Exclusions checklist
Exhibits 186: Currency conversion rates for US$
Exhibits 187: Research methodology
Exhibits 188: Information sources
Exhibits 189: Data validation
Exhibits 190: Validation techniques employed for market sizing
Exhibits 191: Data synthesis
Exhibits 192: 360 degree market analysis
Exhibits 193: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global antimicrobial therapeutics market: AbbVie Inc., Astellas Pharma Inc., Bavarian Nordic AS, Biocidium Biopharmaceuticals Inc., Bristol Myers Squibb Co., Cadila Pharmaceuticals Ltd., CSL Ltd., Emergent BioSolutions Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Johnson and Johnson Services Inc., Merck and Co. Inc., Mitsubishi Corp., Novartis AG, Novavax Inc., Pfizer Inc., Sanofi SA, and Wockhardt Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increase in research and development of therapeutic vaccines."

According to the report, one of the major drivers for this market is the recent drug approvals and robust pipeline.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Bavarian Nordic AS
  • Biocidium Biopharmaceuticals Inc.
  • Bristol Myers Squibb Co.
  • Cadila Pharmaceuticals Ltd.
  • CSL Ltd.
  • Emergent BioSolutions Inc.
  • F. Hoffmann La Roche Ltd.
  • Gilead Sciences Inc.
  • GlaxoSmithKline Plc
  • Inovio Pharmaceuticals Inc.
  • Johnson and Johnson Services Inc.
  • Merck and Co. Inc.
  • Mitsubishi Corp.
  • Novartis AG
  • Novavax Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Wockhardt Ltd.

Related Topics

Related Reports

Antimicrobial Resistance Surveillance Market by Solution (Kits, System, Surveillance Software, Service), Application (Clinical Diagnostics, Public Health Surveillance), End User (Hospitals, Clinics, Academic, Research Institutes) - Global Forecast to 2028 - Product Image

Antimicrobial Resistance Surveillance Market by Solution (Kits, System, Surveillance Software, Service), Application (Clinical Diagnostics, Public Health Surveillance), End User (Hospitals, Clinics, Academic, Research Institutes) - Global Forecast to 2028

  • Report
  • 200 Pages
  • Global
From
Global Antimicrobial Resistance Surveillance Market by Component (Diagnostic Kits, Diagnostic Systems, Services), End-User (Hospitals, Research & Academic Institutes) - Forecast 2024-2030 - Product Image

Global Antimicrobial Resistance Surveillance Market by Component (Diagnostic Kits, Diagnostic Systems, Services), End-User (Hospitals, Research & Academic Institutes) - Forecast 2024-2030

  • Report
  • 198 Pages
  • Global
From
Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, With Executive Guides and Customization 2023 to 2027 - Product Image

Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, With Executive Guides and Customization 2023 to 2027

  • Report
  • 373 Pages
  • Global
From
Antimicrobial Resistance Surveillance - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

Antimicrobial Resistance Surveillance - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 105 Pages
  • Global
From
Antimicrobial Resistance Surveillance Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F - Product Image

Antimicrobial Resistance Surveillance Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.